You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hematopoietic stem cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen Children's Hospital
Feb 24, 2023

Lymphoma Trial in Chongqing (PEG-rhG-CSF, RhG-CSF)

Recruiting
  • Lymphoma
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Aug 31, 2023

Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)

Not yet recruiting
  • Thalassemia, Beta
  • Thalassemia Major
  • VGB-Ex01
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Sep 11, 2023

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

ß-thalassemia Trial in Shanghai (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • Shanghai, China
    Shanghai Ruijin Hospital
Mar 16, 2023

Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

Not yet recruiting
  • Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 18, 2023

ß Thalassemia Major Trial in Shanghai (?-globin reactivated autologous hematopoietic stem cells)

Active, not recruiting
  • β Thalassemia Major
  • γ-globin reactivated autologous hematopoietic stem cells
  • Shanghai, Shanghai, China
    Shanghai Bioray Laboratories Inc.
Oct 9, 2022

Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and

Recruiting
  • Granuloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

    Recruiting
    • Multiple Myeloma
    • Total Marrow irradiation，TMI
    • Autologous hematopoietic stem cell transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jul 24, 2023

    Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

    Not yet recruiting
    • Hematologic Malignancy
    • +5 more
    • autologous hematopoietic stem cells added to planned CAR T
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 31, 2023

    Malignant Lymphoma, Multiple Myeloma Trial (Pentaisomaltose)

    Not yet recruiting
    • Malignant Lymphoma
    • Multiple Myeloma
    • Pentaisomaltose
    • (no location specified)
    Jan 5, 2023

    Thalassemia Major Trial in Shanghai (?-globin reactivated autologous hematopoietic stem cells)

    Not yet recruiting
    • Thalassemia Major
    • γ-globin reactivated autologous hematopoietic stem cells
    • Shanghai, Shanghai, China
      Shanghai Bioray Laboratories Inc
    Jul 1, 2022

    Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)

    Not yet recruiting
    • Glioblastoma
    • 18F-GE-180 PET
    • +4 more
    • Rozzano, (mi), Italy
      IRCCS Istituto Clinico Humanitas
    Oct 27, 2023

    B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

    Recruiting
    • B-Cell Lymphoid Malignancies
    • +2 more
    • Hematopoietic Stem Cells from HLA-compatible Related
    • Hematopoietic Stem Cells from HLA Unrelated
    • Miami, Florida
      Miami Cancer Institute at Baptist Health of South Florida
    May 5, 2022

    Alterations in Intestinal Microbiota, Metabolites, and Immune

    Recruiting
    • Graft Vs Host Disease
    • Blood Sample
    • +2 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Nov 16, 2023

    Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

    Completed
    Has Results
    • Multiple Myeloma
    • Stanford, California
      Stanford University
    Aug 17, 2022

    Sickle Cell Disease Trial in Birmingham, Palo Alto, Saint Louis (GPH101 Drug Product)

    Active, not recruiting
    • Sickle Cell Disease
    • GPH101 Drug Product
    • Birmingham, Alabama
    • +2 more
    Jan 5, 2023

    Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

    Not yet recruiting
    • Sickle Cell Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 8, 2022

    ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

    Recruiting
    • β-thalassemia
    • β-globin restored autologous hematopoietic stem cells
    • Shenzhen, Guangdong, China
      Shenzhen University General Hospital
    May 8, 2023

    a-thalassemia Trial in Nanning (a-globin restored autologous hematopoietic stem cells)

    Recruiting
    • α-thalassemia
    • α-globin restored autologous hematopoietic stem cells
    • Nanning, Guangxi, China
      PLA Joint Logistic Support Force No. 923 Hospital
    May 6, 2023

    Storage of Umbilical Cord Stem Cells for Treatment of Sickle

    Recruiting
    • Sickle Cell Disease
    • Sickle Cell Trait
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Intestinal Microbiome Dynamics in Solid Organ and Stem Cell

      Enrolling by invitation
      • Transplantation Infection
      • +4 more
      • Intestinal microbiome new generation sequencing
      • Minsk, Belarus
        Minsk Scientific-Practical Center for Surgery, Transplantation a
      Aug 28, 2022

      AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

      Not yet recruiting
      • AML
      • +5 more
      • Infusion of CD34 selected hematopoietic stem cells
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Sep 14, 2023

      Hematological Cancer Trial (interviews with coachs, semi-structured interviews and questionnaires, semi-structured interviews

      Not yet recruiting
      • Hematological Cancer
      • interviews with coachs, semi-structured interviews and questionnaires
      • semi-structured interviews and questionnaires
      • (no location specified)
      Aug 1, 2022

      Ovarian Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)

      Recruiting
      • Ovarian Cancer
      • Autologous blood transfusion with haematopoietic stem cells
      • Chongqing, Chongqing, China
        Chongqing University Cancer Hospital
      May 29, 2022